Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Sensors (Basel, Switzerland)
|
April 9, 2020
Mass Sensors Based on Capacitive and Piezoelectric Micromachined Ultrasonic Transducers-CMUT and PMUT
H Nazemi, J Antony Balasingam, S Swaminathan, et al.
Blood
|
July 27, 2001
STAT3 is constitutively activated in Hodgkin cell lines
D Kube, U Holtick, M Vockerodt, et al.
Magnetic Resonance Imaging
|
August 10, 2000
Changes in the liver parenchyma after proton beam radiotherapy: evaluation with MR imaging
H Onaya, Y Itai, H Yoshioka, et al.
Bone Marrow Transplantation
|
November 15, 2011
Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance
T Ahmadi, J McQuade, D Porter, et al.
Clinical Pharmacology and Therapeutics
|
November 19, 2016
Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma
X S Xu, X Yan, T Puchalski, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Sensors (Basel, Switzerland)
|
April 9, 2020
Mass Sensors Based on Capacitive and Piezoelectric Micromachined Ultrasonic Transducers-CMUT and PMUT
H Nazemi, J Antony Balasingam, S Swaminathan, et al.
Blood
|
July 27, 2001
STAT3 is constitutively activated in Hodgkin cell lines
D Kube, U Holtick, M Vockerodt, et al.
Magnetic Resonance Imaging
|
August 10, 2000
Changes in the liver parenchyma after proton beam radiotherapy: evaluation with MR imaging
H Onaya, Y Itai, H Yoshioka, et al.
Bone Marrow Transplantation
|
November 15, 2011
Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance
T Ahmadi, J McQuade, D Porter, et al.
Clinical Pharmacology and Therapeutics
|
November 19, 2016
Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma
X S Xu, X Yan, T Puchalski, et al.
Page
of 3